Viking Therapeutics Stock (NASDAQ: VKTX) stock price, news, charts, stock research, profile.
Open | $64.05 |
Close | $64.63 |
Volume / Avg. | 2.24M / 3.93M |
Day Range | $63.02 - $65.32 |
52 Wk Range | 8.28 - 99.41 |
Market Cap | $7.17B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 20.48% |
Days to Cover | 3.17 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Viking Therapeutics (NASDAQ:VKTX) through any online brokerage.
Other companies in Viking Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and Sarepta Therapeutics (NASDAQ:SRPT).
Viking Therapeutics has a consensus price target of $79.86.
The stock price for Viking Therapeutics (NASDAQ: VKTX) is $64.7 last updated August 23, 2024 at 7:52 PM EDT.
There are no upcoming dividends for Viking Therapeutics.
Viking Therapeutics’s Q3 earnings are confirmed for Wednesday, October 23, 2024.
There is no upcoming split for Viking Therapeutics.
Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.